Market Overview

CannabisNewsBreaks – GreenStar Biosciences Corp. (CSE: GSTR) (OTC: GTSIF) Secures DTC Eligibility

Share:

GreenStar Biosciences (CSE:GSTR) (OTC:GTSIF), a growth-oriented technology and services company that provides real estate, financial, management and other support to licensed cannabis businesses in the U.S., on Thursday announced that it has secured DTC eligibility by The Depository Trust Company ("DTC") for electronic settlement and transfer of its common shares in the United […]

GreenStar Biosciences (CSE:GSTR) (OTC:GTSIF), a growth-oriented technology and services company that provides real estate, financial, management and other support to licensed cannabis businesses in the U.S., on Thursday announced that it has secured DTC eligibility by The Depository Trust Company ("DTC") for electronic settlement and transfer of its common shares in the United States. A subsidiary of the Depository Trust & Clearing Corporation ("DTCC"), the DTC manages the electronic clearing and settlement of publicly traded companies. Securities eligible for this electronic clearing method are considered "DTC eligible," with the method speeding up the receipt of stock and cash, and accelerating the settlement process for investors and brokers. "Together with our recent OTC listing, having our securities made DTC eligible should further enhance trading liquidity and provide additional exposure to U.S. and institutional investors," GreenStar CEO Rahim Rajwani said in the news release.

To view the full press release, visit http://cnw.fm/k3GzC

About GreenStar

GreenStar is a growth-oriented technology and services company that provides real estate, financial, management, IP and branding support to licensed cannabis businesses in the United States. The Company operates a growing portfolio of tenant partner companies in the United States. GreenStar applies refined strategies tested in the Washington State market to help partner companies reach their full potential. Based in Vancouver, BC, GreenStar intends to facilitate growth through acquisitions and development of additional assets, products and technologies in legal cannabis markets by leveraging its capital markets, branding and operational expertise. For more information, visit the company's website at www.GreenStarBiosciences.com.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com